Form 4: KORU Medical Systems Director Cascella Acquires Shares

Director Robert Cascella of KORU Medical Systems, Inc. reports the acquisition of 3,937 shares of common stock at $3.81 per share on January 3, 2025.

Summary

• On January 3, 2025, Robert Cascella, a director of KORU Medical Systems, Inc., acquired 3,937 shares of common stock.
• The shares were purchased at a price of $3.81 per share.
• Following the transaction, Cascella's direct ownership in KORU Medical Systems totals 74,556 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates a director's recent purchase of company stock.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.

Key Dates